These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
284 related items for PubMed ID: 7499212
1. TOR mutations confer rapamycin resistance by preventing interaction with FKBP12-rapamycin. Lorenz MC, Heitman J. J Biol Chem; 1995 Nov 17; 270(46):27531-7. PubMed ID: 7499212 [Abstract] [Full Text] [Related]
2. Interaction between FKBP12-rapamycin and TOR involves a conserved serine residue. Stan R, McLaughlin MM, Cafferkey R, Johnson RK, Rosenberg M, Livi GP. J Biol Chem; 1994 Dec 23; 269(51):32027-30. PubMed ID: 7528205 [Abstract] [Full Text] [Related]
6. Dominant missense mutations in a novel yeast protein related to mammalian phosphatidylinositol 3-kinase and VPS34 abrogate rapamycin cytotoxicity. Cafferkey R, Young PR, McLaughlin MM, Bergsma DJ, Koltin Y, Sathe GM, Faucette L, Eng WK, Johnson RK, Livi GP. Mol Cell Biol; 1993 Oct 23; 13(10):6012-23. PubMed ID: 8413204 [Abstract] [Full Text] [Related]
9. RAFT1: a mammalian protein that binds to FKBP12 in a rapamycin-dependent fashion and is homologous to yeast TORs. Sabatini DM, Erdjument-Bromage H, Lui M, Tempst P, Snyder SH. Cell; 1994 Jul 15; 78(1):35-43. PubMed ID: 7518356 [Abstract] [Full Text] [Related]
10. FAP1, a homologue of human transcription factor NF-X1, competes with rapamycin for binding to FKBP12 in yeast. Kunz J, Loeschmann A, Deuter-Reinhard M, Hall MN. Mol Microbiol; 2000 Sep 15; 37(6):1480-93. PubMed ID: 10998178 [Abstract] [Full Text] [Related]
14. RAPT1, a mammalian homolog of yeast Tor, interacts with the FKBP12/rapamycin complex. Chiu MI, Katz H, Berlin V. Proc Natl Acad Sci U S A; 1994 Dec 20; 91(26):12574-8. PubMed ID: 7809080 [Abstract] [Full Text] [Related]
17. High-sensitivity sequencing of large proteins: partial structure of the rapamycin-FKBP12 target. Erdjument-Bromage H, Lui M, Sabatini DM, Snyder SH, Tempst P. Protein Sci; 1994 Dec 20; 3(12):2435-46. PubMed ID: 7756997 [Abstract] [Full Text] [Related]
18. Rapamycin and less immunosuppressive analogs are toxic to Candida albicans and Cryptococcus neoformans via FKBP12-dependent inhibition of TOR. Cruz MC, Goldstein AL, Blankenship J, Del Poeta M, Perfect JR, McCusker JH, Bennani YL, Cardenas ME, Heitman J. Antimicrob Agents Chemother; 2001 Nov 20; 45(11):3162-70. PubMed ID: 11600372 [Abstract] [Full Text] [Related]
19. Rapamycin antifungal action is mediated via conserved complexes with FKBP12 and TOR kinase homologs in Cryptococcus neoformans. Cruz MC, Cavallo LM, Görlach JM, Cox G, Perfect JR, Cardenas ME, Heitman J. Mol Cell Biol; 1999 Jun 20; 19(6):4101-12. PubMed ID: 10330150 [Abstract] [Full Text] [Related]
20. The fission yeast TOR homolog, tor1+, is required for the response to starvation and other stresses via a conserved serine. Weisman R, Choder M. J Biol Chem; 2001 Mar 09; 276(10):7027-32. PubMed ID: 11096119 [Abstract] [Full Text] [Related] Page: [Next] [New Search]